Navigation Links
Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) First Quarter 2008 Financial Results Call Set for May 6
Date:4/29/2008

able worldwide. This panel includes the only FDA-approved test for human papillomavirus (HPV), the primary cause of cervical cancer.

QIAGEN employs more than 2,700 people in over 30 locations worldwide. Further information about QIAGEN can be found at http://www.qiagen.com.

(Minimum Requirements to listen to broadcast: The RealPlayer software, downloadable free from http://www.real.com/products/player/index.html, or The Windows Media Player, downloadable free from http://www.microsoft.com and at least a 14.4Kbps connection to the Internet. If you experience problems listening to the broadcast, send an email to webmaster@vdat.com.)


'/>"/>
SOURCE QIAGEN N.V.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Exelixis Announces September 5 Webcast of Its 2007 IASLC Investor and Analyst Briefing
2. Gen-Probe Announces Webcast of Third Quarter 2007 Earnings Conference Call
3. PharmAthene to Webcast its Third Quarter Conference Call on November 13, 2007 at 4:30 P.M. Eastern Time
4. Nuvelo Announces Alfimeprase SONOMA-2 Catheter Occlusion Data Presentation Webcast and Conference Call
5. QIAGEN N.V. (Nasdaq: QGEN) Invites You to Join Its Third Quarter 2007 Earnings Conference Call on the Web
6. QIAGEN and Center for Molecular Medicine Create Research Collaboration for Molecular Diagnostic Markers for Breast Cancer, Other Womens Health Issues
7. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
8. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
11. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... BETHESDA, Md. , Sept. 30, 2014 ... "Company") (Nasdaq: CHDX ) today announced the ... ("Healthy Harmony") for $24.00 per share in cash.  Healthy ... (Group) Co., Ltd. ("Fosun") and Ms. Roberta Lipson ... previously announced merger agreement was adopted by Chindex,s stockholders ...
(Date:9/29/2014)... PARIS , Sept. 30, 2014 /PRNewswire/ ... SAN and NYSE: SNY) today announced that a Phase ... blocks IL-4 and IL-13 signaling, met all primary and ... nasal polyps (CSwNP) who did not respond to intranasal ... of dupilumab for use in the treatment of another ...
(Date:9/29/2014)... CHICAGO , Sept. 29, 2014 ... clinical trials are conducted according to good clinical ... the HOPA Investigational Drug Service Best Practice Standards, ... best practice standards and guidance for pharmacists and ... Drug Service Best Practice Standards emphasizes the critical ...
Breaking Medicine Technology:Chindex Completes Go-Private Transaction With Healthy Harmony Holdings, L.P. 2Chindex Completes Go-Private Transaction With Healthy Harmony Holdings, L.P. 3Chindex Completes Go-Private Transaction With Healthy Harmony Holdings, L.P. 4Chindex Completes Go-Private Transaction With Healthy Harmony Holdings, L.P. 5Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 2Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 3Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 4Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 5Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 6Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 7HOPA Introduces First Investigational Drug Service Best Practice Standards For Institutions And Infusion Clinics 2HOPA Introduces First Investigational Drug Service Best Practice Standards For Institutions And Infusion Clinics 3
... , SAN DIEGO, Oct. 7 CareFusion Corporation (NYSE: CFN ... fiscal 2010 on Tuesday, Nov. 10 following the close of trading ... a webcast and conference call on Nov. 10 at 2:00 pm ... its first quarter, ended on Sep. 30, 2009. To access the ...
... Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce ... be demonstrated at the 95th Annual American College of ... Illinois. During the Breast Ductoscopy for the General Surgeon ... to hands-on skill stations that will provide the core ...
Cached Medicine Technology:CareFusion Will Host An Earnings Conference Call on November 10, 2009 to Discuss the Results for the First Quarter of Fiscal 2010 2Solos Endoscopy, Inc.'s MammoView(TM) Product Line to be Demonstrated at the 95th Annual American College of Surgeons Clinical Congress 2
(Date:9/30/2014)... In honor of National Breast Cancer Awareness ... courageous battles, Incredible Veins, Body & Skin is offering ... Cynosure. , “For cancer patients who receive radiation ... on their skin to accurately aim the radiation on ... survivors, they decide to have their tattoo removed as ...
(Date:9/30/2014)... Every New Year begins with a Resolution that will soon ... of effort, however most are out of mind in 30. Why? ... Instead of "spend more time with children", try something easy to ... Without a reminder, daily life gets in the way and efforts ... 3. Goals out of sight equals goals out of mind. ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 From October ... be exhibiting at the 2014 SHSMD Connections Annual Conference ... for Healthcare Strategy & Market Development (SHSMD) is proud ... marketing, public relations and communications, and strategic planning professionals ... About SHSMD Connections , The conference is a ...
(Date:9/30/2014)... Albany, IN (PRWEB) September 30, 2014 ... Dr. Ron Receveur encourages all persons who have received ... disease in a recent blog post. , The post, ... those with dental implants that if they don’t brush ... the same way people lose their natural teeth: the ...
(Date:9/30/2014)... Chicago, IL (PRWEB) September 30, 2014 ... cannabinoid clash,” opened Bryan W. Brickner, “and it’s ... Sleep Political Cannabinoid Science , new on the ... sleep research from the National Institutes of Health ... articles regarding: de-homeostatic sleep disturbances, REM transitions, aging ...
Breaking Medicine News(10 mins):Health News:Incredible Veins, Body & Skin Takes A Stand Against Breast Cancer With PicoSure® By Cynosure 2Health News:MMS, Inc. (Medical Marketing Service) to Attend the 2014 SHSMD Connections Annual Conference in October 2Health News:All on Four Dental Implants Dentist Writes Blog on Preventing Gum Disease 2Health News:All on Four Dental Implants Dentist Writes Blog on Preventing Gum Disease 3Health News:Homeostasis: Publius’ Sleep Political Cannabinoid Science ~ New on the Bryan William Brickner Blog 2
... at Children,s National Medical Center and the ... the results of the first successful application of "multiple ... muscular dystrophy in an animal larger than a ... "DNA band-aids" to skip over the parts of the ...
... SAN DIEGO, March 16 Gen-Probe Incorporated (Nasdaq: ... (AIM: TED) approved the acquisition of Tepnel by Gen-Probe by ... London earlier today.More than 99% of Tepnel shareholders voted in ... 30, 2009 and is structured as a "scheme of arrangement" ...
... Office Building Project Provides State-of-the-Art Healthcare for Rural ... Roads Ventures (HRV), a community development investment firm, ... program to provide equity and debt financing for ... rural communities in Virginia providing successful solutions to ...
... products contain allergens no matter what ingredients are listed, study ... number of food products with a "may contain" label actually ... of foods products without such a claim also contain allergens, ... came from smaller companies, noted the authors of a study ...
... March 16 /PRNewswire-Asia-FirstCall/ -- China Yongxin Pharmaceuticals, Inc. ... Board: CYXN), a leading manufacturer, distributor and retailer ... it has rolled out its Electronic Diagnosis System ... Changchun, Jilin. In order to ensure safety of ...
... adventure series results from a life of creative ... Ohio, March 16 Randy Patterson has spent ... a deadly, aggressive and extremely rare cancer called ... nine grueling spinal taps, mounting financial debt, and ...
Cached Medicine News:Health News:First treatment for muscular dystrophy in sight: Scientists successfully harness exon-skipping 2Health News:First treatment for muscular dystrophy in sight: Scientists successfully harness exon-skipping 3Health News:Tepnel Shareholders Approve Acquisition by Gen-Probe 2Health News:Tepnel Shareholders Approve Acquisition by Gen-Probe 3Health News:Tepnel Shareholders Approve Acquisition by Gen-Probe 4Health News:Hampton Roads Ventures Tackles U.S. Healthcare Crisis Community by Community 2Health News:Food Allergy Labeling Not Always Accurate 2Health News:Food Allergy Labeling Not Always Accurate 3Health News:China Yongxin Pharmaceuticals Inc. Launches Electronic Diagnosis System in its Changchun Drugstores 2Health News:China Yongxin Pharmaceuticals Inc. Launches Electronic Diagnosis System in its Changchun Drugstores 3Health News:Trinadgey Launches to Sci-Fi Lovers via New Online Portal Trinadgey.com 2
For the qualitative detection of group A streptococcal antigen from throat swabs....
For the measurement of vaginal pH as part of a self examination programme to help reduce the risk of pre-term birth...
For the qualitative detection of human Chorionic Gonadotrophin (hCG) in urine specimens...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Medicine Products: